Mirion Technologies has over 40 years of experience protecting people, property and the environment from the harmful effects of ionizing radiation. With over 740 employees worldwide, Mirion has 14 production facilities in Europe, Asia, and North America. Mirion Technologies is comprised of three primary divisions: dosimetry services (“GDS”), nuclear systems (“IST”), and health physics (“Synodys”). Globally these divisions provide the highest quality products and services to a wide range of customers including nuclear power plants, military and civil defense agencies, hospitals, university and national laboratories, and other specialized industries.

Mirion Technologies was created through the merger of three companies owned by American Capital Strategies, LTD (Nasdaq: ACAS): Synodys Group, Imaging and Sensing Technologies, and Global Dosimetry Solutions. The merger created a dominant global player with revenue of roughly $150 million in 2005.

At the core of Mirion Technologies is a dedicated team with unmatched experience and know-how. The Company is well - positioned to extend its global franchise, based upon the renaissance of the global nuclear power industry; strong global demand for homeland security and defense solutions; and increased utilization of radiological medical applications. Mirion will continue to maintain a technology leadership position through innovative products and solutions.

To learn more please visit our website at: www.miriontech.com